»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Àΰ£È ¸¶¿ì½º ¸ðµ¨ ½ÃÀåÀº 2024-2029³â 6,160¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Àΰ£È ¸¶¿ì½º ¸ðµ¨ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àü¹Ý¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·áÀÇ Ã¤Åà Ȯ´ë, Àΰ£È ¸¶¿ì½º ¸ðµ¨ÀÇ Çõ½ÅÀûÀÎ Àû¿ë, À¯Àü°øÇÐ ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³âºñ
6.5%
CAGR
6.7%
Áõ°¡¾×
6,160¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â°£ Àΰ£È ¸¶¿ì½º ¸ðµ¨ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ±â¾÷ÀÇ Àü·«Àû Á¦ÈÞ¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, mabsÀÇ »ý»ê·® Áõ°¡¿Í Àüü µ¿¹° À̹Ì¡ÀÇ ÃâÇöÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤¿ë·ü¡¤±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå »óȲ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀå Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024³â
½ÃÀå Àü¸Á 2024-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
Àΰ£È ¸¶¿ì½º ¸ðµ¨ ¼¼°è ½ÃÀå 2019-2023³â
Á¦Ç° À¯Çüº° ºÎ¹® ºÐ¼® 2019-2023³â
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2019-2023³â
¿ëµµº° ºÎ¹® ºÐ¼® 2019-2023³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : Àΰ£È ¸¶¿ì½º ¸ðµ¨ ¼¼°è ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô Âü¿©¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå »óȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç° À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : Á¦Ç° À¯Çüº°
GHMM : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¿ ±â¹Ý Àΰ£È ¸¶¿ì½º ¸ðµ¨ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Á¦Ç° À¯Çüº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
CRO : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Çмú¿¬±¸±â°ü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
Á¾¾çÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¸é¿ªÇаú °¨¿°Áõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½Å°æ°úÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶¹°Çаú Á¶Ç÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ¿ëµµº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Altogen labs
Aragen Life Sciences Pvt. Ltd.
Biocytogen Pharmaceuticals Co. Ltd.
BioSafety Research Center Inc.
Champions Oncology Inc.
Charles River Laboratories International Inc.
Creative Biolabs
Cyagen Biosciences
Gempharmatech Co. Ltd.
GenOway
HBM Holdings Ltd.
Hera Biolabs Inc.
ingenious targeting laboratory
JSR Corp.
Perkin Elmer Inc.
Á¦16Àå ºÎ·Ï
ksm
The humanized mouse model market is forecasted to grow by USD 61.6 mn during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 6.5%
CAGR 6.7%
Incremental Value $61.6 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's humanized mouse model market is segmented as below:
By Product Type
GHMM
Cell-based humanized mouse model
By End-user
Pharmaceutical and biotechnology companies
CROs
Academic and research institutions
By Application
Oncology
Immunology and infectious diseases
Neuroscience
Toxicology and hematopoiesis
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the strategic alliances of companies as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of mabs and emergence of whole animal imaging will lead to sizable demand in the market.
The report on the humanized mouse model market covers the following areas:
Humanized Mouse Model Market sizing
Humanized Mouse Model Market forecast
Humanized Mouse Model Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Humanized Mouse Model Market 2019 - 2023
Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
5.2 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Humanized Mouse Model Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type
8.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
8.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
8.3 GHMM - Market size and forecast 2024-2029
Chart on GHMM - Market size and forecast 2024-2029 ($ million)
Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
Chart on GHMM - Year-over-year growth 2024-2029 (%)
Data Table on GHMM - Year-over-year growth 2024-2029 (%)
8.4 Cell-based humanized mouse model - Market size and forecast 2024-2029
Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 CROs - Market size and forecast 2024-2029
Chart on CROs - Market size and forecast 2024-2029 ($ million)
Data Table on CROs - Market size and forecast 2024-2029 ($ million)
Chart on CROs - Year-over-year growth 2024-2029 (%)
Data Table on CROs - Year-over-year growth 2024-2029 (%)
9.5 Academic and research institutions - Market size and forecast 2024-2029
Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Immunology and infectious diseases - Market size and forecast 2024-2029
Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
10.5 Neuroscience - Market size and forecast 2024-2029
Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
10.6 Toxicology and hematopoiesis - Market size and forecast 2024-2029
Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.11 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Altogen labs
Altogen labs - Overview
Altogen labs - Product / Service
Altogen labs - Key offerings
SWOT
15.5 Aragen Life Sciences Pvt. Ltd.
Aragen Life Sciences Pvt. Ltd. - Overview
Aragen Life Sciences Pvt. Ltd. - Product / Service
Aragen Life Sciences Pvt. Ltd. - Key offerings
SWOT
15.6 Biocytogen Pharmaceuticals Co. Ltd.
Biocytogen Pharmaceuticals Co. Ltd. - Overview
Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
SWOT
15.7 BioSafety Research Center Inc.
BioSafety Research Center Inc. - Overview
BioSafety Research Center Inc. - Product / Service
BioSafety Research Center Inc. - Key offerings
SWOT
15.8 Champions Oncology Inc.
Champions Oncology Inc. - Overview
Champions Oncology Inc. - Product / Service
Champions Oncology Inc. - Key offerings
SWOT
15.9 Charles River Laboratories International Inc.
Charles River Laboratories International Inc. - Overview
Charles River Laboratories International Inc. - Business segments
Charles River Laboratories International Inc. - Key offerings
Charles River Laboratories International Inc. - Segment focus
SWOT
15.10 Creative Biolabs
Creative Biolabs - Overview
Creative Biolabs - Product / Service
Creative Biolabs - Key offerings
SWOT
15.11 Cyagen Biosciences
Cyagen Biosciences - Overview
Cyagen Biosciences - Product / Service
Cyagen Biosciences - Key offerings
SWOT
15.12 Gempharmatech Co. Ltd.
Gempharmatech Co. Ltd. - Overview
Gempharmatech Co. Ltd. - Product / Service
Gempharmatech Co. Ltd. - Key offerings
SWOT
15.13 GenOway
GenOway - Overview
GenOway - Product / Service
GenOway - Key offerings
SWOT
15.14 HBM Holdings Ltd.
HBM Holdings Ltd. - Overview
HBM Holdings Ltd. - Product / Service
HBM Holdings Ltd. - Key offerings
SWOT
15.15 Hera Biolabs Inc.
Hera Biolabs Inc. - Overview
Hera Biolabs Inc. - Product / Service
Hera Biolabs Inc. - Key offerings
SWOT
15.16 ingenious targeting laboratory
ingenious targeting laboratory - Overview
ingenious targeting laboratory - Product / Service
ingenious targeting laboratory - Key offerings
SWOT
15.17 JSR Corp.
JSR Corp. - Overview
JSR Corp. - Business segments
JSR Corp. - Key offerings
JSR Corp. - Segment focus
SWOT
15.18 Perkin Elmer Inc.
Perkin Elmer Inc. - Overview
Perkin Elmer Inc. - Business segments
Perkin Elmer Inc. - Key offerings
Perkin Elmer Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations